Growth Metrics

Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011)

Integra Lifesciences Holdings recorded quarterly Land & Improvements of $2.7 million in Q4 2011, down 0.62% quarter-over-quarter from $2.7 million in Q4 2010, and down 0.62% year-over-year from $2.7 million in Q4 2010.

Integra Lifesciences Holdings' Land & Improvements history runs 2 years deep, the most recent figure standing at $2.7 million for Q4 2011.

  • In Q4 2011, Land & Improvements fell 0.62% year-over-year to $2.7 million; the TTM figure through Dec 2011 stood at $2.7 million (down 0.62% YoY), while the FY2011 annual figure was $2.7 million, down 0.62% from the prior year.
  • Land & Improvements came in at $2.7 million for Q4 2011 at Integra Lifesciences Holdings, down from $2.7 million in the prior quarter.
  • In the past five years, Land & Improvements ranged from a high of $2.7 million in Q4 2010 to a low of $2.7 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.80 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 188.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 112.30 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 2.71 Mn
Dec 31, 2010 2.73 Mn